Baker Avenue Asset Management, LP - PROVENTION BIO INC ownership

PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 64 filers reported holding PROVENTION BIO INC in Q4 2019. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Avenue Asset Management, LP ownership history of PROVENTION BIO INC
ValueSharesWeighting
Q2 2021$120,000
-19.5%
14,2500.0%0.01%
-22.2%
Q1 2021$149,000
-56.6%
14,250
-29.6%
0.01%
-60.9%
Q4 2020$343,000
-26.2%
20,250
-44.1%
0.02%
-36.1%
Q3 2020$465,000
-30.3%
36,250
-23.3%
0.04%
-34.5%
Q2 2020$667,000
+4.1%
47,250
-32.3%
0.06%
-27.6%
Q1 2020$641,000
-52.8%
69,750
-23.6%
0.08%
-22.4%
Q4 2019$1,359,00091,2500.10%
Other shareholders
PROVENTION BIO INC shareholders Q4 2019
NameSharesValueWeighting ↓
DG Capital Management, LLC 417,092$5,351,0003.22%
Johnson & Johnson Innovation - JJDC, Inc. 574,973$7,377,0001.48%
Soleus Capital Management, L.P. 139,418$1,789,0000.95%
683 Capital Management, LLC 859,314$11,025,0000.81%
Perceptive Advisors 4,265,711$54,729,0000.80%
GILDER GAGNON HOWE & CO LLC 2,151,402$27,602,0000.17%
Virtus ETF Advisers LLC 21,485$276,0000.14%
RICE HALL JAMES & ASSOCIATES, LLC 230,873$2,962,0000.12%
Windsor Creek Advisors, LLC 28,492$366,0000.10%
Newbridge Financial Services Group, Inc. 6,500$83,0000.08%
View complete list of PROVENTION BIO INC shareholders